瑞图西马布作为怀孕期间耐火性免疫血小板缺血的治疗方法
Maria I Sousa1, António C Braga, Graça C Buchner
1Serviço de Obstetrícia, Departamento da Mulher e da Medicina Reprodutiva, Centro Materno-Infantil do Norte, Unidade Local de Saúde de Santo António, Porto, Portugal.
概括
怀孕期间的免疫性血小板缺血 (ITP) 需要谨慎管理. 这一案例凸显出,虽然ITP通常对怀孕是安全的,但耐火病例可能需要脊髓切除术,而修复剂被认为是手术前的.
科学领域:
- 产科和妇科 产科和妇科
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫性血小板缺血 (ITP) 是怀孕早期血小板数量较低的最常见原因.
- 虽然ITP通常对母亲和新生儿有有利的结果,但有些病例存在挑战.
- 区分ITP与其他与怀孕相关的血小板缺血症至关重要.
研究的目的:
- 报告在怀孕早期诊断的免疫性血小板缺血病例.
- 审查关于在妊娠期间管理耐火ITP的文献.
- 为了评估孕妇患者ITP的治疗策略.
主要方法:
- 一个怀孕患者的病例报告,患有ITP,对初始治疗不耐药.
- 在怀孕期间对ITP管理的文献综述.
- 对治疗结果的分析,包括类固醇,IVIG,rituximab和脊髓切除术.
主要成果:
- 这位患者的ITP对高剂量类固醇,IVIG和rituximab耐药.
- 在脊髓切除术后的第三季度实现了血小板计数的控制.
- 利图西马布在这种特定情况下是无效的,但仍然是手术前的考虑因素.
结论:
- 免疫性血小板缺血通常不是怀孕的禁忌.
- 怀孕期间耐火性ITP可能需要作为最后手段进行脊髓切除术.
- 在患有耐火性ITP的孕妇患者中,应该考虑Rituximab作为手术前的选择.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
128
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
128
01:19Rh Blood Group
1.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K